# TCGA Data Analysis Report

**Date**: 2025-12-31
**Dataset**: The Cancer Genome Atlas (TCGA)
**Total Patients**: 11,330 across 33 cancer types

## Executive Summary

✅ **Successfully downloaded TCGA clinical data**
❌ **Cannot test cancer prediction model on TCGA data**

**Reason**: TCGA lacks the metabolic biomarkers (lactate, LDH, CRP, glucose) required by our model.

## What We Downloaded

### Dataset Overview

- **Patients**: 11,330
- **Cancer Types**: 33 different cancer types
- **Time Period**: Downloaded 2025-12-31
- **Data Type**: Clinical and demographic data
- **Size**: ~500MB

### Available Data Fields

| Field | Completeness | Description |
|-------|--------------|-------------|
| case_id | 100% | Unique patient identifier |
| submitter_id | 100% | TCGA patient ID |
| project | 100% | Cancer type (e.g., TCGA-BRCA) |
| gender | 98.9% | Male/Female |
| race | 98.9% | Patient race |
| ethnicity | 98.9% | Hispanic/Non-Hispanic |
| vital_status | 98.9% | Alive/Dead |
| **age_at_diagnosis** | **92.5%** | **Age in years** ✅ |
| primary_diagnosis | 98.9% | Cancer type diagnosis |
| tissue_or_organ | 98.9% | Affected organ |
| tumor_stage | 0% | Tumor staging (not populated) |

### Top Cancer Types

| Cancer Type | Patients | Description |
|-------------|----------|-------------|
| TCGA-BRCA | 1,000 | Breast Invasive Carcinoma |
| TCGA-GBM | 617 | Glioblastoma Multiforme |
| TCGA-OV | 608 | Ovarian Serous Cystadenocarcinoma |
| TCGA-LUAD | 585 | Lung Adenocarcinoma |
| TCGA-UCEC | 560 | Uterine Corpus Endometrial Carcinoma |
| TCGA-KIRC | 537 | Kidney Renal Clear Cell Carcinoma |
| TCGA-HNSC | 528 | Head and Neck Squamous Cell Carcinoma |
| TCGA-LGG | 516 | Brain Lower Grade Glioma |
| TCGA-THCA | 507 | Thyroid Carcinoma |
| TCGA-LUSC | 504 | Lung Squamous Cell Carcinoma |

## Model Requirements vs TCGA Data

### Our Model Requires (7 features):

1. ❌ **Lactate (mM)** - NOT AVAILABLE
2. ❌ **CRP (mg/L)** - NOT AVAILABLE
3. ❌ **Specific Gravity** - NOT AVAILABLE
4. ❌ **Glucose (mM)** - NOT AVAILABLE
5. ❌ **LDH (U/L)** - NOT AVAILABLE
6. ✅ **Age** - AVAILABLE (92.5% complete)
7. ❌ **BMI** - NOT AVAILABLE

### Missing Data: 6 out of 7 features (85.7%)

## Critical Issues for Model Testing

### Issue #1: Missing Biomarker Data

TCGA clinical data does **not include** serum laboratory test results for:
- Lactate
- LDH (Lactate Dehydrogenase)
- CRP (C-Reactive Protein)
- Glucose
- Specific Gravity
- BMI (Body Mass Index)

These metabolic biomarkers are the **core features** of our cancer detection model.

### Issue #2: All Patients Have Cancer (Label Imbalance)

- **TCGA patients**: 100% have cancer (label = 1)
- **Control group**: 0% (no healthy patients)

**Impact**: Cannot evaluate model's ability to distinguish cancer from non-cancer.

Our model is trained to differentiate:
- Cancer patients (label = 1)
- Healthy controls (label = 0)

Without healthy controls, we can only evaluate:
- ❌ Sensitivity (true positive rate) - NO healthy controls to test against
- ❌ Specificity (true negative rate) - NO healthy controls
- ❌ AUC-ROC - Requires both classes
- ❌ Overall accuracy - Requires both classes

### Issue #3: Gene Expression ≠ Serum Levels

TCGA does contain:
- Gene expression data for LDHA, LDHB genes
- Transcriptomic profiles

However:
- Gene expression ≠ Serum lactate levels
- mRNA levels ≠ Protein activity levels
- Our model needs **serum biomarker measurements**, not gene expression

## What Would Be Needed

### To Test Model on TCGA Patients

We would need access to TCGA's **biospecimen** data with:

1. **Serum metabolic panel**:
   - Lactate measurements
   - LDH enzyme activity
   - CRP levels
   - Glucose levels

2. **Additional clinical measurements**:
   - Urine specific gravity
   - BMI calculation (height/weight)

3. **Matched controls**:
   - Healthy individuals with same biomarkers
   - Age and demographics matched
   - Required for proper evaluation

### Where to Find This Data

TCGA may have this data in:
- **GDC Data Portal** → Biospecimen data
- **Clinical supplements** → Lab values (if collected)
- **Legacy archive** → Older data formats

**Action Required**:
1. Search GDC for "clinical laboratory" files
2. Download biospecimen supplements
3. Check for chemistry panel data
4. May require additional data access requests

## Alternative: Use MIMIC-IV Instead

**Recommendation**: Use MIMIC-IV dataset instead of TCGA

### Why MIMIC-IV is Better for Our Use Case

| Feature | TCGA | MIMIC-IV |
|---------|------|----------|
| Lactate measurements | ❌ | ✅ |
| Glucose measurements | ❌ | ✅ |
| LDH measurements | ❌ | ❓ (check) |
| CRP measurements | ❌ | ❓ (check) |
| Cancer patients | ✅ (11,330) | ✅ (subset) |
| Healthy controls | ❌ | ✅ (365,000+) |
| Lab test timestamps | ❌ | ✅ |
| Can test model | ❌ | ✅ |

### MIMIC-IV Access

- **Time**: ~1 week for credentialing
- **Cost**: Free
- **Process**: PhysioNet registration + CITI training
- **Data**: Complete lab panels with timestamps

## Interim Use of TCGA Data

While we can't test the model, TCGA data is still valuable for:

### 1. **Cancer Type Analysis**
```python
# Analyze cancer type distribution
import pandas as pd
df = pd.read_csv('tcga/tcga_all_clinical.csv')
print(df['project'].value_counts())
```

### 2. **Age Distribution Validation**
```python
# Compare TCGA age distribution to our synthetic data
tcga_age_mean = df['age_at_diagnosis'].mean()  # 59.3 years
# Our synthetic: cancer patients aged 40-90
```

### 3. **Demographics for Future Model Enhancement**
- Race/ethnicity data
- Gender distribution
- Organ-specific cancer patterns

### 4. **Gene Expression Integration (Future)**
If we download TCGA gene expression data:
- Correlate LDHA/LDHB expression with outcomes
- Identify metabolic gene signatures
- Could build complementary genomic model

## Next Steps

### Immediate Actions

1. ✅ **TCGA Downloaded** - Keep for reference
2. ⏳ **Apply for MIMIC-IV Access**
   - Start PhysioNet credentialing
   - Complete CITI training
   - Sign data use agreement
3. ⏳ **Search for TCGA Lab Data**
   - Check GDC for clinical supplements
   - Look for biospecimen data
   - May require separate download

### Medium-term Actions

4. **Download MIMIC-IV** (after credentialing)
   - Full lab events table
   - Cancer patient IDs
   - Extract biomarkers

5. **Test Model on MIMIC-IV**
   - Real lactate, glucose measurements
   - Cancer vs healthy controls
   - True model validation

### Long-term Actions

6. **Apply for PLCO/UK Biobank**
   - Larger cancer cohorts
   - Comprehensive metabolomics
   - Multi-center validation

## Conclusion

**TCGA Download: Successful ✅**
- 11,330 cancer patients
- 33 cancer types
- Rich clinical data

**Model Testing: Not Possible ❌**
- Missing 6/7 required biomarkers
- No healthy controls
- Need alternative dataset

**Recommendation: Proceed with MIMIC-IV**
- Has required biomarkers
- Has healthy controls
- Enables true model validation
- 1 week to access

## Files Generated

```
external_datasets/tcga/
├── TCGA-BRCA_clinical.csv        # Breast cancer (1,000 patients)
├── TCGA-LUAD_clinical.csv        # Lung adenocarcinoma (585 patients)
├── TCGA-PAAD_clinical.csv        # Pancreatic cancer (185 patients)
├── ... (30 more cancer types)
└── tcga_all_clinical.csv         # Combined (11,330 patients)
```

## References

- TCGA: https://www.cancer.gov/tcga
- GDC Data Portal: https://portal.gdc.cancer.gov/
- TCGA Publications: https://www.cell.com/pb-assets/consortium/pancanceratlas/pancani3/index.html

---

**Report Generated**: 2025-12-31
**Analyst**: Cancer Predictor Model Team
